Literature DB >> 23633235

Cardiac and respiratory dysfunction in Duchenne muscular dystrophy and the role of second messengers.

Matias Mosqueira1, Ulrike Zeiger, Moritz Förderer, Heinrich Brinkmeier, Rainer H A Fink.   

Abstract

Duchenne muscular dystrophy (DMD) affects young boys and is characterized by the absence of dystrophin, a large cytoskeletal protein present in skeletal and cardiac muscle cells and neurons. The heart and diaphragm become necrotic in DMD patients and animal models of DMD, resulting in cardiorespiratory failure as the leading cause of death. The major consequences of the absence of dystrophin are high levels of intracellular Ca(2+) and the unbalanced production of NO that can finally trigger protein degradation and cell death. Cytoplasmic increase in Ca(2+) concentration directly and indirectly triggers different processes such as necrosis, fibrosis, and activation of macrophages. The absence of the neuronal isoform of nitric oxide synthase (nNOS) and the overproduction of NO by the inducible isoform (iNOS) further increase the intracellular Ca(2+) via a hypernitrosylation of the ryanodine receptor. NO overproduction, which further induces the expression of iNOS but decreases the expression of the endothelial isoform (eNOS), deregulates the muscle tissue blood flow creating an ischemic situation. The high levels of Ca(2+) in dystrophic muscles and the ischemic state of the muscle tissue would culminate in a positive feedback loop. While efforts continue toward optimizing cardiac and respiratory care of DMD patients, both Ca(2+) and NO in cardiac and respiratory muscle pathways have been shown to be important to the etiology of the disease. Understanding the mechanisms behind the fine regulation of Ca(2+) -NO may be important for a noninterventional and noninvasive supportive approach to treat DMD patients, improving the quality of life and natural history of DMD patients.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  Ca2+-NO signaling; cardiomyopathy; dystrophin; skeletal muscle; ventilation

Mesh:

Substances:

Year:  2013        PMID: 23633235     DOI: 10.1002/med.21279

Source DB:  PubMed          Journal:  Med Res Rev        ISSN: 0198-6325            Impact factor:   12.944


  27 in total

1.  Autonomic dysfunction: a driving force for myocardial fibrosis in young Duchenne muscular dystrophy patients?

Authors:  Tamara O Thomas; John L Jefferies; Angela Lorts; Jeffrey B Anderson; Zhiqian Gao; D Woodrow Benson; Kan N Hor; Linda H Cripe; Elaine M Urbina
Journal:  Pediatr Cardiol       Date:  2014-11-16       Impact factor: 1.655

2.  Lack of the serum- and glucocorticoid-inducible kinase SGK1 improves muscle force characteristics and attenuates fibrosis in dystrophic mdx mouse muscle.

Authors:  Martin Steinberger; Michael Föller; Silke Vogelgesang; Mirjam Krautwald; Martin Landsberger; Claudia K Winkler; Joachim Kasch; Ernst-Martin Füchtbauer; Dietmar Kuhl; Jakob Voelkl; Florian Lang; Heinrich Brinkmeier
Journal:  Pflugers Arch       Date:  2014-11-14       Impact factor: 3.657

Review 3.  What has the mdx mouse model of Duchenne muscular dystrophy contributed to our understanding of this disease?

Authors:  Jennifer Manning; Dervla O'Malley
Journal:  J Muscle Res Cell Motil       Date:  2015-02-11       Impact factor: 2.698

4.  Sensorimotor control of breathing in the mdx mouse model of Duchenne muscular dystrophy.

Authors:  David P Burns; Arijit Roy; Eric F Lucking; Fiona B McDonald; Sam Gray; Richard J Wilson; Deirdre Edge; Ken D O'Halloran
Journal:  J Physiol       Date:  2017-10-09       Impact factor: 5.182

Review 5.  Treatment of dystrophin cardiomyopathies.

Authors:  Josef Finsterer; Linda Cripe
Journal:  Nat Rev Cardiol       Date:  2014-01-14       Impact factor: 32.419

6.  Absence of full-length dystrophin impairs normal maturation and contraction of cardiomyocytes derived from human-induced pluripotent stem cells.

Authors:  J Manuel Pioner; Xuan Guan; Jordan M Klaiman; Alice W Racca; Lil Pabon; Veronica Muskheli; Jesse Macadangdang; Cecilia Ferrantini; Michael R Hoopmann; Robert L Moritz; Deok-Ho Kim; Chiara Tesi; Corrado Poggesi; Charles E Murry; Martin K Childers; David L Mack; Michael Regnier
Journal:  Cardiovasc Res       Date:  2020-02-01       Impact factor: 10.787

7.  Autophagy regulates satellite cell ability to regenerate normal and dystrophic muscles.

Authors:  E Fiacco; F Castagnetti; V Bianconi; L Madaro; M De Bardi; F Nazio; A D'Amico; E Bertini; F Cecconi; P L Puri; L Latella
Journal:  Cell Death Differ       Date:  2016-07-22       Impact factor: 15.828

8.  Free-breathing variable flip angle balanced SSFP cardiac cine imaging with reduced SAR at 3T.

Authors:  Subashini Srinivasan; Randall M Kroeker; Simon Gabriel; Adam Plotnik; Sergio R Godinez; Peng Hu; Nancy Halnon; J Paul Finn; Daniel B Ennis
Journal:  Magn Reson Med       Date:  2015-10-28       Impact factor: 4.668

9.  Diaphragm degeneration and cardiac structure in mdx mouse: potential clinical implications for Duchenne muscular dystrophy.

Authors:  Isabel Cristina Chagas Barbin; Juliano Alves Pereira; Matheus Bersan Rovere; Drielen de Oliveira Moreira; Maria Julia Marques; Humberto Santo Neto
Journal:  J Anat       Date:  2016-01-29       Impact factor: 2.610

Review 10.  Stem Cell Differentiation Toward the Myogenic Lineage for Muscle Tissue Regeneration: A Focus on Muscular Dystrophy.

Authors:  Serge Ostrovidov; Xuetao Shi; Ramin Banan Sadeghian; Sahar Salehi; Toshinori Fujie; Hojae Bae; Murugan Ramalingam; Ali Khademhosseini
Journal:  Stem Cell Rev Rep       Date:  2015-12       Impact factor: 6.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.